11/16/2021, 8:06 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Pfizer Inc

Pfizer seeks emergency use authorization of COVID pill in US

Pfizer submitted on Tuesday its application to the United States Food and Drug Administration (FDA) for emergency use authorization of its COVID-19 pill, Paxlovid.

Pfizer noted that clinical trials showed the treatment reduces the risk of hospitalization or death due to COVID-19 by 89% in high-risk individuals who were exposed to the virus.

Earlier, the pharmaceutical giant said it expects its oral coronavirus drug to be available in the United Kingdom in early 2022.

Baha Breaking News (BBN) / NP